Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML.

Saved in:
Bibliographic Details
Title: Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML.
Authors: Nguyen NHK; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, FL., Rafiee R; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, FL., Tagmount A; Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL., Sobh A; UF Health Cancer Center, Gainesville, FL., Loguinov A; Department of Physiological Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL., de Jesus Sosa AK; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, FL., Elsayed AH; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, FL., Gbadamosi M; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, FL., Seligson N; Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Jacksonville, FL., Cogle CR; Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL., Rubnitz J; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Ribeiro R; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Downing J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN., Cao X; University of Tennessee Health Science Center, Memphis, TN., Pounds SB; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, TN., Vulpe CD; UF Health Cancer Center, Gainesville, FL., Lamba JK; Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, FL.
Source: Blood advances [Blood Adv] 2023 May 09; Vol. 7 (9), pp. 1769-1783.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2022007934